Bright Minds Biosciences to Host Symposium on Therapeutic Developments within Dravet Syndrome and Featuring a Panel with Key Opinion Leaders
— Review of Phase I ready BMB-101 and upcoming milestones — — Conference call to be held on May 19, 2022, 10:00am ET — Vancouver, BC – April 19, 2022 – Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the…
